Skip to main content
Collection

MHRA strategy blog series

A series of articles from influential external voices about the challenges and opportunities ahead.

Updates to this page

From:
Medicines and Healthcare products Regulatory Agency
Published:
16 October 2025
Last updated:
14 October 2026
Show all updates

  1. A link to the MHRA 2030 strategy has been added.

  2. Added the final blog in the strategy series.

  3. Added latest blog: Professor Dame Anna Dominiczak, Professor Alison Strath, and Fiona Cohrane: Catalysing the medicines ecosystem in Scotland

  4. Added Cari Anne Quinn Blog: Turning possibility into progress health innovation in Wales

  5. Added: Professor Joann Rhodes: The Rules Need to Bend – Why Flexible Policies and Real Partnership are the Keys to unlocking Life Sciences Potential

  6. How to seize the growing opportunities of AI and technology ahead blog added to this page.

  7. Added the Shaping the Future of Healthcare Through Global Regulatory Innovation blog post

  8. Updated to add latest blog post - The £1.4bn opportunity: How reclassification can transform healthcare, improve access to medicines and enable growth

  9. Updated to add Regulation as an Enabler of Innovation: A Regional Perspective to strat blog series

  10. Updated to add Mila to Millions: A New Era of Individualized Medicines to Strat blog series

  11. Added new blog: ‘Professor Sir Aziz Sheikh: Towards next-generation pharmacovigilance capabilities for the UK’

  12. Updated to include latest Strategy Blog post: Professor Bola Owolabi CBE: Creating the Climate for Health Equity

  13. Added latest in the series of guest blogs: 'Professor Alastair Denniston: The future regulation of AI in healthcare'

  14. Published latest in the series of guest blogs: 'Professor Henrietta Hughes: Putting Patient Safety at the Heart of Regulatory Innovation'

  15. First published.

As the UK regulator for medicines and healthcare products, the MHRA plays a central role in shaping the future of health and life sciences. 

To support the development of our strategy to 2030, we published a series of blogs on the challenges and opportunities ahead. This series welcomed in important voices across academia, industry and the patient community to stimulate informed discussion on regulatory approaches that balance safety, innovation and trust.

On 14 October 2026, the MHRA has published its 2030 Strategy, setting out how we will modernise regulation to keep pace with rapid advances in science, technology and personalised healthcare while continuing to put patients first.

Read the MHRA strategy 2030.

Blogs

Contents

Related content